# Evaluation of the Impact of Lock Down and End of Lock Down on the Management of Patients With Inflammatory and Dysimmune Diseases Followed in the Context of IMMINeNT FHU and COVID-19

> **NCT04513561** · — · COMPLETED · sponsor: **University Hospital, Lille** · enrollment: 921 (actual)

## Conditions studied

- Inflammatory Disease
- Covid19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04513561
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-21
- **Primary completion:** 2020-08-27
- **Final completion:** 2020-08-27
- **Target enrollment:** 921 (ACTUAL)
- **Last updated:** 2021-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04513561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04513561, "Evaluation of the Impact of Lock Down and End of Lock Down on the Management of Patients With Inflammatory and Dysimmune Diseases Followed in the Context of IMMINeNT FHU and COVID-19". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04513561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*